Genentech is withdrawing its troubled immunosuppressant drug, Raptiva, from the market, because of a link to a rare brain infection. (If Raptiva sounds familiar, that may be a result of its link to a couple of research scandals, which appear to be unrelated. See here and here.)
No comments:
Post a Comment